Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
07/03/1991 | CN1052669A Chroman and thiochroman derivatives |
07/03/1991 | CN1052668A Compounds for treating inflammatory bowel disease |
07/03/1991 | CN1052667A 唑衍生物 derivatives |
07/03/1991 | CN1052664A Antithrombotic compounds |
07/03/1991 | CN1052659A Fluoro-naphthacenediones, their glycosilated derivatives and their manufacture procedures |
07/03/1991 | CN1052607A Cell cycle-dependent regulation of phosphorylation of human retion blastoma gene product |
07/03/1991 | CN1013037B Process for the mfr. of novel triazolopyrimidine |
07/03/1991 | CA2033363A1 Quinazoline derivatives and their preparation |
07/02/1991 | US5028733 Prostaglandins |
07/02/1991 | US5028730 Antihypercholesterolemic nitrile compounds |
07/02/1991 | US5028727 Platinum-(IV)-diamine complex |
07/02/1991 | US5028711 Hypotensive Agents |
07/02/1991 | US5028698 Cytorhodin S derivatives and a process for their preparation |
07/02/1991 | US5028664 Drug-release controlling coating material for long acting formulations |
07/02/1991 | US5028630 Benzylamines |
07/02/1991 | US5028628 Methods of treating pulmonary hypertension |
07/02/1991 | US5028627 Controlling blood pressure during chemotherapy |
07/02/1991 | US5028625 Chewable Tablet For Oral Administration |
07/02/1991 | US5028624 Treatment of glaucoma |
07/02/1991 | US5028622 Administration of amino acids as treatment for neurodegenerative disorders |
07/02/1991 | US5028621 Drugs comprising porphyrins |
07/02/1991 | US5028620 Biocide composition |
07/02/1991 | US5028617 Livestock, controlling obesity in humans |
07/02/1991 | US5028615 Quinoline derivatives as antagonists of leukotriene D4 |
07/02/1991 | US5028614 Hydroxymethyl-indolizidines and quinolizidines and their use as α-glucosidase I inhibitors |
07/02/1991 | US5028612 Method for treating emotional numbness |
07/02/1991 | US5028611 Treatment for cocaine use |
07/02/1991 | US5028609 Alkyl diamine derivatives |
07/02/1991 | US5028607 Bis(aryl)alkene compounds |
07/02/1991 | US5028605 Antispasmodic, bronchodilators, uterine relaxants, cardiac analeptics, neurosedatives |
07/02/1991 | US5028603 Platelet-Activating Factor Antagonist; Useful In Treatment Of Inflammatory Diseases, Allergic Diseases, Asthma, Respiratory System Disorders |
07/02/1991 | US5028602 Thieno-(3,4-d)azepines, central nervous system disorders |
07/02/1991 | US5028600 Novel pharmaceutical composition |
07/02/1991 | US5028599 Injecting An Ethylene Oxide-Propylene Oxide Surfactant |
07/02/1991 | US5028598 Viricides, treatment of AIDS |
07/02/1991 | US5028595 Administering 2',3'-Dideoxycytidine |
07/02/1991 | US5028536 Antitumor antibiotic BMY-41339 |
07/02/1991 | US5028439 Inhibition of parathyroid hormone secretion |
07/02/1991 | US5028437 Treatment of animal diarrhoea |
07/02/1991 | US5028434 Drug Delivery |
07/02/1991 | US5028433 Readily absorbable drug formulation of NB-818 |
07/02/1991 | US5028432 Nonaqueous Matrix of Glyceride and/or Mineral Oil or Paraffin |
07/02/1991 | US5028431 Antidermatitis substance |
07/02/1991 | US5028427 Antibiotic |
07/02/1991 | US5028411 Pharmaceutical compositions |
07/02/1991 | CA1285575C Naphthalene anti-psoriatic agents |
07/02/1991 | CA1285572C Di-t-butylphenol compounds |
07/02/1991 | CA1285570C 7-oxabicycloheptane substituted amide-carbamate prostaglandin analogs |
07/02/1991 | CA1285569C 7-oxabicycloheptane substituted amide-thioamide prostalglandin analogs |
07/02/1991 | CA1285566C 2,3,5,6,7,8-hexahydro-1-methyl-3-oxo-isoquinoline compounds |
07/02/1991 | CA1285565C 4-cyano-2,3,5,6,7,8-hexahydro-3-oxo-isoquinoline compounds |
07/02/1991 | CA1285564C 1-heteroaryl-4-¬(2,5-pyrrolidinedion-1-yl)alkyl|piperazine derivatives |
07/02/1991 | CA1285563C Ureidoalkanoylaminocarbonyl amino and imino acids and esters |
07/02/1991 | CA1285562C Quinone derivatives, their production and use |
07/02/1991 | CA1285561C Naphthoxazines |
07/02/1991 | CA1285560C Derivatives of guanine |
07/02/1991 | CA1285554C Method for preparing crystalline cefadroxil monohydrate |
07/02/1991 | CA1285528C Preparation of electrolyte solutions and containers |
07/02/1991 | CA1285491C Method of treating catabolic dysfunction |
07/02/1991 | CA1285489C Process for the preparation of stabilized isosorbide- 5-mononitrate tablets, being also of sustained release, and formulations thus obtained |
07/02/1991 | CA1285488C Pharmaceutical formulation containing indomethacin |
07/02/1991 | CA1285487C Stable solid preparation of thiol ester derivative |
07/02/1991 | CA1285486C Method for production of stable nicorandil preparation |
07/02/1991 | CA1285485C Nicorandil-containing preparation for injection |
07/02/1991 | CA1285484C Chlorpheniramine therapy |
07/02/1991 | CA1285482C Sustained-release pharmaceutical preparation |
06/30/1991 | WO1991009857A1 Heterocyclic derivatives, method for preparing same, and their therapeutic applications |
06/30/1991 | CA2222658A1 Intermediates in preparation of new phenylethanolaminomethyltetralins |
06/30/1991 | CA2032289A1 Substituted 5-(alkyl) carboxamide imidazoles |
06/30/1991 | CA2031479A1 Chroman esters of phenols and benzoic acids having retinoid-like activity |
06/29/1991 | WO1991009594A1 Sigma receptor ligands and the use thereof |
06/29/1991 | CA2071897A1 Sigma receptor ligands and the use thereof |
06/29/1991 | CA2033303A1 2-aminopyrimidine-4-carboxamide derivatives, their preparation and their application in therapeutics |
06/29/1991 | CA2033121A1 Diaza compounds |
06/29/1991 | CA2032251A1 Cyclopropyl derivative lipoxygenase inhibitors |
06/29/1991 | CA2031469A1 Use of inclusion complexes of prostaglandins with cyclodextrins in the treatment of ocular hypertension |
06/28/1991 | WO1991009859A1 New xanthine derivatives |
06/28/1991 | WO1991009611A1 Drug for preventing and treating fish diseases |
06/28/1991 | CA2072602A1 Drug for preventing and treating fish diseases |
06/28/1991 | CA2033118A1 Intravenous solutions for status epileptious |
06/28/1991 | CA2032974A1 Process for the preparation of glycosylanthracyclinones |
06/28/1991 | CA2032973A1 Aminopyridinylmethanols and aminomethylpyridinamines and related compounds, a process for their preparation and their use as medicaments |
06/28/1991 | CA2032972A1 Benzanthracene compound and a process for preparing the same |
06/28/1991 | CA2032885A1 Substituted 3,4-annelated benzimidazol-2(1h)-ones |
06/27/1991 | WO1991009831A1 Prodrug anhydrides of asprin, indomethacin and ibuprofen, their preparation, compositions, and anti-inflammatory method of use |
06/27/1991 | WO1991009114A1 Cell-cycle-dependent regulation of phosphorylation of human retinoblastoma gene product |
06/27/1991 | WO1991009056A1 Octapeptide analogs of somatostatin having threonine at the sixth position |
06/27/1991 | WO1991009046A1 Morpholinyl derivatives of doxorubicin and process for their preparation |
06/27/1991 | WO1991009038A1 Cephalosporins, processes for their preparation, intermediates and pharmaceutical compositions containing them |
06/27/1991 | WO1991009020A2 PRODUCTION OF 5-(4'-HYDROXYPHENYL)HYDANTOIN AND D-p-HYDROXYPHENYLGLYCINE FROM 4-HYDROXYACETOPHENONE |
06/27/1991 | WO1991009019A1 Substituted oxophthalazinyl acetic acids and analogs thereof |
06/27/1991 | WO1991009017A1 Quinoline derivatives, their production and use |
06/27/1991 | WO1991008746A1 Killing of activated lymphocytes |
06/27/1991 | WO1991008745A1 Compositions and methods for preventing and treating rotaviral infections |
06/27/1991 | WO1991008743A1 Circumvention of human tumor drug resistance |
06/27/1991 | WO1991008742A1 Treatment of tremor using calcium-current-depressing compounds |
06/27/1991 | WO1991008741A1 Use of cromakalim/brl 38227 for the treatment of hyperreactivity of airways |
06/27/1991 | WO1991008740A1 The use of gaba-b selective agonists as anti-tussive agents |
06/27/1991 | WO1991008735A1 Pharmaceutical preparations |
06/27/1991 | WO1991008667A1 Inhibitors of pneumocystis carinii dihydrofolate reductase |